Canopy Growth Faces Nasdaq Delisting Risk After Shares Fall Below $1.00 Minimum

Key highlights

• Nasdaq deficiency notice received on October 14, 2026, due to 30 consecutive days of sub-$1.00 prices
• Compliance deadline set for April 12, 2027, requiring a $1.00 closing price for 10 consecutive days
• Company is seeking shareholder approval for a reverse stock split at a meeting on October 23, 2026
• Notice does not immediately impact the current listing on the Nasdaq Global Select Market
• Stock has declined 25.18% over the last quarter, currently trading at approximately $0.713

Nasdaq Compliance Timeline

The Nasdaq Global Select Market notified Canopy Growth that its common shares failed to maintain the $1.00 minimum bid price for 30 consecutive business days, violating Listing Rule 5450(a)(1). While the notice does not immediately impact the company’s current listing, Canopy Growth must restore its share price to at least $1.00 for ten consecutive business days before the April 12, 2027 deadline. To address this, management has proposed a share consolidation, or reverse stock split, which will be put to a shareholder vote at the reconvened annual meeting on October 23, 2026. Failure to regain compliance could lead to a transfer to the Nasdaq Capital Market or eventual delisting procedures.

Up 0.0% since our story on 16 Oct: $0.71 when we broke it → $0.71 at the close on 16 Oct. Daily closing prices. Source: Yahoo Finance.

Show the prices

16 Sep	$0.92
17 Sep	$0.94
18 Sep	$0.93
21 Sep	$0.92
22 Sep	$0.97
23 Sep	$0.94
24 Sep	$0.93
25 Sep	$0.94
28 Sep	$0.93
29 Sep	$0.93
30 Sep	$0.90
1 Oct	$0.88
2 Oct	$0.88
5 Oct	$0.89
6 Oct	$0.89
7 Oct	$0.88
8 Oct	$0.85
9 Oct	$0.83
12 Oct	$0.76
13 Oct	$0.76
14 Oct	$0.71
15 Oct	$0.74
16 Oct	$0.71

Remediation and Extension Options

• Nasdaq provided an initial 180-day compliance period ending April 12, 2027.
• The company must maintain a $1.00 closing price for ten consecutive business days to satisfy requirements.
• Any potential reverse stock split must be completed at least ten business days before the deadline.
• A second 180-day extension may be available if the company moves to the Nasdaq Capital Market.
• Listing status on the Toronto Stock Exchange is currently unaffected by the Nasdaq notice.

Business Operations and Expansion

Based in Smiths Falls, Ontario, Canopy Growth operates as a diversified cannabis and consumer packaged goods company across medical and recreational markets. Recently, the company secured European Union Good Manufacturing Practice (EU GMP) certification for its Smiths Falls facility, enabling expanded medical cannabis exports to international markets like Germany. The company also finalized the acquisition of MTL Cannabis Corp earlier in 2026, a strategic move intended to strengthen its presence in the premium flower market. These operational developments occur as the company continues its focus on the United States market through its Canopy USA ecosystem.

Financial Position and Outlook

Canopy Growth reported quarterly revenue of $81.16 million for the period ending June 30, 2026. Despite the stock price pressure and a relative strength index of 22.7—indicating technically oversold conditions—management has reaffirmed its target to achieve positive Adjusted EBITDA in fiscal year 2027. The company recently stabilized its balance sheet through a $162 million recapitalization involving a new senior secured term loan. With an annual revenue base of $284.60 million and a current market capitalization of $301.6 million, the company is prioritizing operational efficiencies to mitigate the impact of the recent 25.18% quarterly share price decline.

Canopy Growth Corp · financial snapshot

Share price	$0.71
Market cap	$302M
Revenue (annual)	$285M
1-month price change	-22.16%
Sector	HealthcareDrug Manufacturers - Specialty & Generic

Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.